Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
172.82
+0.50 (+0.29%)
Streaming Delayed Price
Updated: 10:03 AM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AbbVie
< Previous
1
2
3
4
5
6
7
Next >
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV): The Winning Streak Continues
February 15, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
Via
Investor Brand Network
AbbVie Inc. (ABBV) Climbs to Annual-High Share Price
February 04, 2022
Via
Investor Brand Network
Watch for Continued Gains in Shares of AbbVie Inc. (ABBV)
February 02, 2022
Via
Investor Brand Network
Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)
January 24, 2022
Via
AB Newswire
New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024
January 10, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 10, 2021 – USA News Group – Nearly 10% of the estimated ~1.9 million new cancer cases in the USA will be diagnosed as...
Via
FinancialNewsMedia
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
January 06, 2022
Via
AB Newswire
Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028
January 04, 2022
Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss,...
Via
FinancialNewsMedia
Exposures
COVID-19
AbbVie Inc. (ABBV) Looks to Continue to Trade Above its Annual-High Share Price Today
December 27, 2021
Via
Investor Brand Network
Watch for Continued Gains in Shares of AbbVie Inc. (ABBV)
December 16, 2021
Via
Investor Brand Network
Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027
December 08, 2021
Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...
Via
FinancialNewsMedia
Is This The Most Exciting Medical Breakthrough Of The Decade
October 19, 2021
FN Media Group Presents Oilprice.com Market Commentary London – October 19, 2021 – According to Google’s Health boss David Feinberg… over one billion people a day search Google for health concerns....
Via
FinancialNewsMedia
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell non-Hodgkin’s Lymphoma (B-NHL) Published in The Lancet
September 09, 2021
From
Genmab A/S
Via
Business Wire
SANUWAVE’s Valuation Could Surge After AbbVie Starts A Bidding War In The Shockwave Sector
June 15, 2021
Via
AB Newswire
With AbbVie Paying $550 Million For Soliton, Inc., SANUWAVE’s Valuation Could Surge 1280% Based On A Comparative Analysis
May 18, 2021
Via
AB Newswire
Here’s Why SANUWAVE Could Be Worth Double The $550 Million AbbVie Paid For Soliton, Inc.
May 14, 2021
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Cognitive Assessment And Training Market Size Expected To Reach $15.65 Billion In 2028
May 04, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
April 08, 2021
Via
FinancialNewsMedia
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.